PDS Biotechnology Corporation Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PDSB, updated each market day.
PDSB AI Sentiment
AI predicts PDS Biotechnology Corporation Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About PDS Biotechnology Corporation Common Stock
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
Sector
Exchange
Market Cap
$59,722,748
Cap Tier
Employees
21
Headquarters
PRINCETON, NJ
Listed Since
Oct. 1, 2015
Website
PDSB Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PDSB Volatility
PDS Biotechnology Corporation Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
